CD274 and non-small cell lung carcinoma: Studies have reported that in advanced NSCLC patients who did not respond to anti-PD-1 or anti-PD-L1 treatment, the levels of miRNA-200c-3p, miRNA-21-5p, and miRNA-28-5p in plasma EVs prior to treatment were elevated (20).